Literature DB >> 12162396

Hepatocellular carcinoma: current approaches to diagnosis and management.

G W McCaughan1, D J Koorey, S I Strasser.   

Abstract

Hepatocellular carcinoma, frequently associated with chronic viral hepatitis, is the fourth most common cancer worldwide. The incidence in Western countries is rising rapidly. Recent developments in diagnostic imaging allow for identification of small lesions amenable to curative therapy. Effective therapy of advanced hepatocellular carcinoma remains a major clinical problem.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12162396     DOI： 10.1046/j.1445-5994.2002.00227.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


  8 in total

1.  Radiofrequency ablation of hepatocellular carcinoma: Current status.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-11-28

2.  Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues.

Authors:  Kellie J Archer; Zhongming Zhao; Tobias Guennel; Daniel G Maluf; Robert A Fisher; Valeria R Mas
Journal:  Int J Comput Biol Drug Des       Date:  2010-08-05

3.  Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients.

Authors:  Kellie J Archer; Valeria R Mas; Krystle David; Daniel G Maluf; Karen Bornstein; Robert A Fisher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

4.  Two rare forms of hepatocellular carcinoma metastases.

Authors:  Nicole M Gentile; Kyle M McKenzie; Ryan T Hurt
Journal:  BMJ Case Rep       Date:  2013-06-10

5.  High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.

Authors:  Kellie J Archer; Valeria R Mas; Daniel G Maluf; Robert A Fisher
Journal:  Mol Genet Genomics       Date:  2010-02-18       Impact factor: 3.291

6.  Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.

Authors:  Lauren M Ladd; Temel Tirkes; Mark Tann; David M Agarwal; Matthew S Johnson; Bilal Tahir; Kumaresan Sandrasegaran
Journal:  Clin Mol Hepatol       Date:  2016-12-14

Review 7.  Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity.

Authors:  Corinne E Wessner; Colette M Shaw; Maria Stanczak; Flemming Forsberg; Andrej Lyshchik; Allison Tan; John R Eisenbrey
Journal:  Ultrasound Q       Date:  2020-09       Impact factor: 1.462

Review 8.  Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.

Authors:  Sabrina Bimonte; Maddalena Leongito; Mauro Piccirillo; Cristina de Angelis; Claudia Pivonello; Vincenza Granata; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2016-08-12       Impact factor: 2.965
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.